LexDanaLexDanabeta
Inventor

JENNY P.-Y. TING

Inventor
US

Overview

2→
Patents
2024–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
C12NMicroorganisms or enzymes14%
PatentTitleYear
12,234,480Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells202511,918,621Methods and treatments using toll-like receptor agonists to mitigate hematopoietic myeloid loss, increase gastrointestinal recovery and reduce tumor growth2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024–2025Patents assigned to UNIV NORTH CAROLINA CHAPEL HILL (2)· patent assignee history
2024–2025Based in US· patent location history
2025Patents assigned to ALBERT LUDWIG UNIV FREIBURG (1)· patent assignee history
2025Patents assigned to ST JUDE CHILDRENS RES HOSPITAL INC (1)· patent assignee history
2025Patents assigned to UNIV FREIBURG ALBERT LUDWIGS (1)· patent assignee history
2025Patents assigned to UNIV MINNESOTA (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV NORTH CAROLINA CHAPEL HILL22024–2025
ALBERT LUDWIG UNIV FREIBURG12025
ST JUDE CHILDRENS RES HOSPITAL INC12025
UNIV FREIBURG ALBERT LUDWIGS12025
UNIV MINNESOTA12025
Locations
LocationPatentsSpan
US22024–2025